BeOne Medicines
ONC
#649
Rank
ยฃ26.83 B
Marketcap
ยฃ242.50
Share price
-2.56%
Change (1 day)
48.91%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Revenue for BeOne Medicines (ONC)

Revenue in 2025 (TTM): ยฃ3.77 Billion

According to BeOne Medicines's latest financial reports the company's current revenue (TTM ) is ยฃ3.73 Billion. In 2024 the company made a revenue of ยฃ3.03 Billion an increase over the revenue in the year 2023 that were of ยฃ1.92 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for BeOne Medicines from 2015 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ3.77 B24.23%
2024 ยฃ3.03 B57.32%
2023 ยฃ1.92 B64.9%
2022 ยฃ1.17 B34.31%
2021 ยฃ0.87 B284.56%
2020 ยฃ0.22 B-30.61%
2019 ยฃ0.32 B109.12%
2018 ยฃ0.15 B-11.47%
2017 ยฃ0.17 B20240.54%
2016 ยฃ0.86 M-85.42%
2015 ยฃ5.94 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Onconova Therapeutics
ONTX
ยฃ0.16 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.48 B-87.09%๐Ÿ‡บ๐Ÿ‡ธ USA